Work

VERTU: Veliparib, radiotherapy (RT) and temozolomide (TMZ) trial in unmethylated MGMT glioblastoma (GBM).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.tps2081

Authors: Mustafa Khasraw, Kerrie Leanne McDonald, Mark Rosenthal, Zarnie Lwin, David M. Ashley, Helen Wheeler, Elizabeth Barnes, Eng-Siew Koh, Matthew C Foote, Michael Buckland, Renee Swanson, Merryn Hall, Sonia Yip, Martinus Oostendorp, John Simes

Institutions: The University of Sydney, National Health and Medical Research Council, UNSW Sydney, The Royal Melbourne Hospital, Royal North Shore Hospital, The University of Queensland, Princess Alexandra Hospital, Royal Prince Alfred Hospital

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2510039329

Cites:

Cited by: 4

Related to: 10